Brief: Abionyx Pharma End-Sept Cash Position Of 3.8 Million Euros
Nov 17 (Reuters) - Abionyx Pharma SA ABNX.PA :
* ABIONYX PHARMA ANNOUNCES ITS CASH POSITION AND PROVIDES AN
ACTIVITY UPDATE ON THE 3RD QUARTER 2022
* CASH POSITION OF €3.8 MILLION (EXCLUDING FRENCH RESEARCH
TAX
CREDIT) AS OF SEPTEMBER 30, 2022
* 9M CONSOLIDATED REVENUE OF €3,789 K
Source text: https://bit.ly/3Ocg1AN
Further company coverage: ABNX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls